ArticleTurkish journal of medical sciences2026
Prevalence of gout in the Sincan district of Ankara, Türkiye: a primary care-based cross-sectional study.
Article in Turkish journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/aim: Gout, the most prevalent form of inflammatory arthritis, has shown a global increase in prevalence; however, data from Türkiye remain scarce, inconsistent, and largely confined to western regions. This study aimed to estimate the prevalence of gout among adults in the Sincan district of Ankara, Türkiye, and to provide updated data from a previously understudied region. Materials and methods: This cross-sectional, community-based study employed a multistage design. Adults aged ≥18 years who presented to selected family health centers in Sincan between February and June 2023 were screened using a structured questionnaire. Individuals with suspected gout underwent comprehensive clinical evaluation, including medical history, physical examination, and relevant laboratory testing, conducted by rheumatologists. Gout was classified according to the 2015 ACR/EULAR criteria, with a score of ≥8 required for classification. Results: Of the 517 individuals approached, 515 provided consent, and data from 513 participants were included in the final analysis. Screening identified 26 individuals with suspected gout, of whom 24 completed evaluation, resulting in the confirmation of seven gout cases (five men and two women). The overall estimated prevalence of gout was 1.36% (95% CI: 0.55%-2.81%). Prevalence was higher in men (2.18%; 95% CI: 0.71%-5.01%) than in women (0.70%; 95% CI: 0.09%-2.52%) although this difference was not statistically significant due to the small sample size, and prevalence increased with age. Conclusion: These findings provide updated epidemiological data, indicating a higher prevalence than previously reported in western Türkiye, while remaining within the lower range of global estimates. These data underscore the need to enhance gout awareness and to develop effective management strategies within the Turkish population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.